Overview

The Effect of Nebivolol in Hypertensive Patients With Coronary Artery Disease

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study is being done to see if the blood pressure lowering effect of an approved drug nebivolol is comparable to that of another approved drug carvedilol for the treatment of hypertension in patients who have coronary artery disease.
Phase:
Phase 4
Details
Lead Sponsor:
Forest Laboratories
Treatments:
Carvedilol
Nebivolol